Drug profile · INN
acalabrutinib maleate
CALQUENCE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
acalabrutinib maleate (CALQUENCE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN acalabrutinib maleate
Brand CALQUENCE
Route ORAL
Formulation TABLET
Frequently asked questions
What is acalabrutinib maleate?
acalabrutinib maleate (CALQUENCE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for acalabrutinib maleate?
CALQUENCE is a marketed brand name for acalabrutinib maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of acalabrutinib maleate?
acalabrutinib maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.